GLP-1 Authority Hub
GLP-1 treatment guides, drug comparisons, dosing, safety, and access.
Start with the basics, then move into semaglutide, tirzepatide, retatrutide, side effects, cost, diet, and the full GLP-1 drug class.
Start here
New to GLP-1 therapy?
These articles explain what GLP-1 does, what incretins are, how receptor agonists work, and which products sit inside the drug class.
What Does GLP-1 Do? A Plain-English Explanation
A plain-English guide to what the GLP-1 hormone does: glucose-dependent insulin release, glucagon suppression, slowed gastric emptying, and appetite control.
What Are Incretins? GLP-1, GIP & the Hormone System Behind Modern Weight Loss Drugs
Incretins are gut hormones, chiefly GLP-1 and GIP, that trigger most of your post-meal insulin release. Here is how the incretin system works and how it powers modern weight-loss drugs.
GLP-1 Receptor Agonist: What the Term Means & Why It Matters for Treatment
A more technical definition of "GLP-1 receptor agonist": what the GLP-1 receptor is, how receptor binding and activation work, and why the precise wording separates these drugs from DPP-4 inhibitors.
GLP-1 Products: Every Approved Option Available in 2026 (Full Reference Guide)
A full 2026 roster of FDA-approved GLP-1 and incretin products, with brand, molecule, maker, indication and delivery form for each option on the market.
Topic hubs
Choose the GLP-1 question you are trying to answer.
Semaglutide
Semaglutide uses, Ozempic, Wegovy, Rybelsus, dosage context, side effects, safety warnings, and GLP-1 comparisons.
Open hub
Tirzepatide
Tirzepatide uses, Mounjaro, Zepbound, dosage context, side effects, warnings, cost, access, and GLP-1 comparisons.
Open hub
Retatrutide
Retatrutide mechanism, clinical trial data, benefits, dosage context, side effects, availability, cost, and comparisons.
Open hub
Side Effects
GLP-1 side effects, nausea, vomiting, diarrhea, constipation, fatigue, reflux, red flags, long-term risks, and management tips.
Open hub
Cost and Access
Coupons, savings programs, prescriptions, telehealth, OTC claims, compounding, and drug-specific cost guides.
Open hub
Diet and Body Composition
Diet, fat loss, muscle retention, protein, plateaus, PCOS, women-specific context, and long-term weight management.
Open hub
Drug List
Approved GLP-1 products, receptor agonists, analogues, diabetes drugs, new drugs, and manufacturer guides.
Open hubQuick map
How the core GLP-1 topics connect.
Semaglutide
Single-receptor GLP-1 benchmark for Ozempic, Wegovy, and related comparison pages.
Tirzepatide
Dual GLP-1/GIP agonist context for Mounjaro, Zepbound, dosing, cost, and side effects.
Retatrutide
Pipeline triple agonist coverage for trial data, dosage, benefits, cost, and safety questions.
Latest
Latest GLP-1 articles
Weight Loss Injections: Your 2026 Options, Ranked by Results and Price
The 2026 weight loss injections compared: semaglutide (Wegovy), tirzepatide (Zepbound), liraglutide (Saxenda), and compounded telehealth options — ranked by results and price, with where to buy each.
Cheapest Tirzepatide in 2026: Every Route Ranked by Real Price
The cheapest tirzepatide is $25 a fill with the right insurance and Lilly's card. Cash payers: compounded from ~$146/month, LillyDirect Zepbound vials at $299-$449, SingleCare at $408.68 — and a $1,100/month Mounjaro trap to step around.
Retatrutide and Heart Rate: Increases, Risks, and What to Watch
Retatrutide raised resting heart rate by roughly 6 to 7 beats per minute at the highest doses in its phase 2 trial, peaking near week 24 and easing afterward. Here is what the data shows, why it happens, and when a faster pulse warrants attention.
Retatrutide for Genetic Obesity and GLP-1 Resistance
Genetic obesity (most often MC4R pathway defects) and so-called GLP-1 resistance describe people who lose less weight than expected on standard drugs. This guide explains the biology and where an investigational triple agonist like retatrutide may help.
Retatrutide and Type 1 Diabetes: What's Known and the Risks
Retatrutide is an investigational triple agonist with no published type 1 diabetes trials. Here is what the broader GLP-1 evidence shows, why glucagon agonism complicates the picture, and the DKA and hypoglycemia risks that drive caution.
Losing Too Much Weight on Retatrutide: Why It Happens and What to Do
Retatrutide produces the strongest weight loss of any obesity drug studied so far, which means rapid or excessive loss is a real risk. Here is why it happens, the muscle and nutrition dangers, and how to slow it down through dose changes, protein, and strength training.
Retatrutide and Cagrilintide Stack: Rationale, Risks, and Reality
People stack retatrutide (a triple agonist) with cagrilintide (an amylin analogue) hoping to hit appetite from two angles. The synergy is theoretical only. No human trial has tested this combination, and both drugs carry real safety questions.
Retatrutide and MOTS-c Stack: Metabolism, Energy, and Caveats
MOTS-c is a mitochondrial peptide that activates AMPK and is studied for metabolism and exercise. Some pair it with the triple agonist retatrutide, but no human stack data exists. Here is the rationale and the evidence gap.
Can You Combine Tesamorelin and Retatrutide?
Tesamorelin (a GHRH analogue for visceral fat) and retatrutide (an investigational triple agonist) target different pathways, so people ask about stacking them. No combined trial exists, and retatrutide is not FDA approved. Here is the rationale, the interactions, and the cautions.
Retatrutide vs Zepbound: Weight Loss Comparison
Zepbound (tirzepatide) is an FDA-approved dual agonist that produced about 20.9% weight loss in SURMOUNT-1. Retatrutide is an investigational triple agonist that hit 24.2% in phase 2 and up to 28.3% in phase 3, but it is not yet approved.
How to Get Retatrutide in 2026: Every Legitimate Route
Retatrutide is an investigational Eli Lilly drug in Phase 3 trials, so there is no pharmacy or prescription route in 2026. This guide walks the only real path (clinical trial enrollment) plus the honest legal and safety reality of compounded and grey-market 'research' retatrutide.
Retatrutide For Sale: What to Check Before You Buy
Retatrutide is an investigational triple-agonist not approved by the FDA, so every vial sold online is research-use-only. This buyer-protection guide explains how to vet sellers, read a COA, spot scams, and sanity-check pricing before you part with money.
Full library